ANXA1 and breast carcinoma: In a previous study, the Key Laboratory of Breast Cancer in our hospital explored the gemcitabine resistance mechanism, and its microarray data (deposited in the National Center for Biotechnology Information Gene Expression Omnibus database under the accession number GSE63140) revealed an increase of ANXA6 expression but no changes in ANXA1 expression [16].